Predicting drug sensitivity of cancer cells based on DNA methylation levels.
Cancer cell lines, which are cell cultures derived from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug responses for a given cell line based on molecular features may help to optimize drug-development pipelines...
Main Authors: | Sofia P Miranda, Fernanda A Baião, Julia L Fleck, Stephen R Piccolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238757 |
Similar Items
-
The DNA methylation landscape of five pediatric-tumor types
by: Alyssa C. Parker, et al.
Published: (2022-06-01) -
LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer.
by: Linda M Liao, et al.
Published: (2011-01-01) -
DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
by: Galateia Liouta, et al.
Published: (2023-02-01) -
A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
by: Keiko Shinjo, et al.
Published: (2020-01-01) -
Predict drug sensitivity of cancer cells with pathway activity inference
by: Xuewei Wang, et al.
Published: (2019-01-01)